Balaji Amines Limited (BALAMINES) has officially commenced the commercial production of ISOPROPYLAMINE (MIPA/ DIPA) at its Unit-1 facility located in Vill-Tamalwadi Village, Tuljapur Taluka, Osmanabad District, Maharashtra. The announcement was made on June 30, 2025, marking a significant step in the company’s operational expansion.
This development follows the company’s earlier intimation on June 25, 2025, regarding the receipt of consent to operate for manufacturing ISOPROPYLAMINE (MIPA/ DIPA) and the initiation of trial runs. The successful transition to commercial production underscores Balaji Amines’ commitment to enhancing its product portfolio within the specialty chemicals segment.
ISOPROPYLAMINE (MIPA/ DIPA) is categorized as a specialty chemical. The company’s current focus for this product is primarily the domestic market. However, Balaji Amines has indicated that it may explore opportunities to tap into the international market in due course, depending on market opportunities.
The commencement of commercial production is in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. At the time of this announcement, shares of Balaji Amines Limited were trading at ₹1824.5, reflecting a marginal decrease of 0.9%.
source: Corporate Announcement